Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4- thiadiazol-2-yl] piperazinyl quinolone derivatives

Archives of Pharmacal Research

Volumn 30, Issue 2, 2007, Pages 138-145

  Foroumadi, Alireza ^a,b   Firoozpour, Loghman ^a,b   Emami, Saeed ^c   Mansouri, Shahla ^d   Ebrahimabadi, Abdolrasoul H ^b   Asadipour, Ali ^b   Amini, Mohsen ^a   Saeid Adeli, Nosratollah ^d   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,3,4 thiadiazole; In vitro antibacterial activity; N substituted piperazinyl quinolones; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis

Indexed keywords

EID: 33947150934     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977685     Document Type: Article

References (15)

1. Alemagna, A., Bachetti, T., and Beltrame, P., 1,3,4-thiadiazoles-III Nucleophilic reactivity of 2-aryl-5-chloro derivatives. Tetrahedron, 24, 3209-3217 (1968).
2. Anderson, V. E. and Osherhoff, N., Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. Curr. Pharm. Des., 7, 337-353 (2001).
3. th edition, C. V. Mosby: St. Louis, (1990).
4. Chu, D. T., Fernandes, P. B., Claiborne, A. K., Pihuleac, E., Nordeen, C. W., Maleczka, R. E., and Pernet, A. G., Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. J. Med. Chem., 28, 1558-64 (1985).
5. De Sarro, A. and De Sarro, G., Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem., 8, 371-374 (2001).
6. Domagala, J. M., Heifetz, C. L., Hutt, M. P., Mich, T. F., Nichols, J. B., Solomon, M., and Worth, D. F., 1-Substituted 7-[3-[(ethylamino)methyl]-1- pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials. J. Med. Chem., 31, 991-1001 (1988).
7. Emami, S., Shafiee, A., and Foroumadi, A., Structural features of new quinolones and relationship to antibacterial activity against gram-positive bacteria. Mini-Rev. Med. Chem., 6, 375-386 (2006).
8. Fang, K. C., Chen, Y. L., Sheu, J. Y., Wang, T. C., and Tzeng, C. C., Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives. J. Med. Chem., 43, 3809-3812 (2000).
9. Foroumadi, A., Emami, S., Mehni, M., Moshafi, M. H., and Shafiee, A., Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2- oxoethyl] and N-[2-(5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones. Bioorg. Med. Chem. Lett., 20, 4536-4539 (2005a).
10. Foroumadi, A., Emami, S., Hassanzadeh, A., Rajaee, M., Sokhanvar, K., Moshafi, M. H., and Shafiee, A., Synthesis And antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1, 3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. Bioorg. Med. Chem. Lett., 15, 4488-4492 (2005b).
11. Gootz, T. D., McGuirk, P. R., Moynihan, M. S., and Haskell, S. L., Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrob. Agents. Chemother., 38, 130-133 (1994).
12. Hagihara, M., Kashiwase, H., Katsube, T., Kimura, T., Komai, T., Momota, K., Ohmine, T., Nishigaki, T., Kimura, S., and Shimada, K., Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents. Bioorg. Med. Chem. Lett., 9, 3063-3068 (1999).
13. Pandeya, S. N., Sriram, D., Nath, G., and De Clercq, E., Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin mannich bases. Eur. J. Med. Chem., 35, 249-255 (2000).
14. Shafiee, A. and Foroumadi, A., Synthesis of arylsulfonyl-1,3,4- thiadiazoles. J. Heterocycl. Chem., 33, 1611-1614 (1996).
15. Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W., Cooper, C. S., Rosen, T., and Pernet, A. G., Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry, 28, 3886-3894 (1989).